Thereby, these two ligands interact with PD-1 on activated T-cells, which induces the inhibition [6] resulting in the down regulation of the immune response during resolution of an infection, during development of self-tolerance, or within the tumor microenvironment. The gene discussed is PDCD1; the disease is neoplasm.